Is Saccharomyces Boulardii Gut Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Saccharomyces Boulardii Gut Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - boulardii in PCOS women did not affect weight, BMI, or FBS but reduced testosterone and DHEA-S levels. [Pourkarim F (2026); evidence level 2] - Objective Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that affects women during their reproductive age, which may cause infertility. [Pourkarim F (2026); evidence level 2] - We aimed to evaluate the effect of probiotic supplementation on metabolic parameters and androgen levels in women with PCOS. [Pourkarim F (2026); evidence level 2] - These benefits include modulation of the gut microbiota, enhancement of immune function, and alleviation of symptoms associated with gastrointestinal disorders. [Dong Z (2026); evidence level 3] - The review also covers advances in genetic engineering approaches aimed at enhancing its probiotic functions, as well as the technical, regulatory, and safety limitations associated with its application in food products. [Dong Z (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.